... Huang and Konan Peck for theSARS-CoV N protein cDNAs, plasmids and recombi-nant proteins, and Chwan-Deng Hsiao and Yi-WeiChang for CD analysis. We thank Ru-Inn Lin and Wei-Lun Chang for their ... the RS motif formed high-order RNP complexes, whichmay also account for its enhanced stress granule localization. Takentogether, phosphorylation of the severeacuterespiratory syndrome- CoVnucleocapsid ... (N) and phosphorylated (pN) N proteins (lanes 2 and 4). Lanes 1 and 3 are the mock reactionswithout crosslinker. The right-hand panel shows the relative abundance (percentage) of monomer and...
... remission and free fromimmunosuppressive drugs for 7 months, before presentingwith a further relapse. A more intensive treatment wasperformed (Figure 1) with cyclophosphamide 10mg/kg/day for 10 ... ussomethingwww.casesnetwork.comCase reportOpen AccessProlonged extracorporeal membrane oxygenation therapy for severeacuterespiratory distress syndrome in a child affected byrituximab-resistant autoimmune hemolytic anemia: ... amikacin, ceftazi-dime, G-CSF and voriconazole was started. Within a fewhours, her clinical condition deteriorated and the patientdeveloped AcuteRespiratory Distress Syndrome (ARDS),which required...
... ventilation in the treatment of acuterespiratory failure in severeacuterespiratory syndrome. Chest (in press) 44. Liu X.Q., et al. Management of critical severeacuterespiratorysyndromeand risk ... regimens in severeacuterespiratory syndrome. Am J Respir Crit Care Med, 2003. 168:1449-56. 35. Lau ACW and So LKY. Severeacuterespiratorysyndrome treatment: present status and future strategy. ... patients with severeacuterespiratory syndrome. Emerg Infect Dis, 2003. 9:1058–1063. 11. So L.K.Y., et al. Development of a standard treatment protocol forsevereacuterespiratory syndrome. ...
... Poon E, CheungTM & Yam LY (2004) Outcome of coronavirus-associ-ated severeacuterespiratorysyndrome using a standard treatment protocol. Respirology 9, 173–183.8 Barnard DL, Day CW, Bailey ... QX, Gao YW, Zhou HQ, Xiang H et al.(2005) Cross-host evolution of severeacute respiratory syndrome coronavirus in palm civet and human. ProcNatl Acad Sci USA 102, 2430–2435.6 Lau SK, Woo PC, ... fact that tertiary and quaternary structures canbe predicted for SARS-CoV helicase [13] allows adeeper insight into the function ⁄ structure correlations for native and mutated forms of the viral...
... certainadvantages during the replication of the severeacuterespiratory syndrome- coronavirus.BackgroundThe recent severeacuterespiratorysyndrome (SARS) epi-demic, which affected over 30 ... University SARS Research Team:Characterization of severeacuterespiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution. Proc Natl Acad Sci USA 2004,101:2542-2547.BioMed ... 2004,101:2542-2547.BioMed CentralPage 1 of 5(page number not for citation purposes)Virology JournalOpen AccessHypothesisThe SevereAcuteRespiratorySyndrome (SARS)-coronavirus 3a protein may function...
... certainadvantages during the replication of the severeacuterespiratory syndrome- coronavirus.BackgroundThe recent severeacuterespiratorysyndrome (SARS) epi-demic, which affected over 30 ... that areBioMed CentralPage 1 of 5(page number not for citation purposes)Virology JournalOpen AccessHypothesisThe SevereAcuteRespiratorySyndrome (SARS)-coronavirus 3a protein may function ... vitro.Presentation of the hypothesis: It has been shown that the severeacuterespiratory syndrome- coronavirus genome contains open reading frames that encode for proteins with no homologue inother coronaviruses....
... reserved Research Paper Lamivudine treatmentforsevereacute HBV hepatitis Andrea Lisotti, Francesco Azzaroli, Federica Buonfiglioli, Marco Montagnani, Flavio Alessandrelli, Giuseppe Mazzella ... drugs for the treatment of hepatitis B (i.e. entecavir and telbivudine) might be even better in reaching a rapid decrease in viral load and a faster recovery in patients with ful-minant or severe ... Published: 2008.10.23 Treatment foracute hepatitis B is recommended in order to reduce the risk of progression to fulminant hepatitis and the need of OLT. We report our experience on treatment with...
... AccessTask shifting and integration of HIV care intoprimary care in South Africa: The development and content of the streamlining tasks and rolesto expand treatmentand care for HIV (STRETCH)interventionKerry ... al.: Task shifting and integration of HIV careinto primary care in South Africa: The development and content of thestreamlining tasks and roles to expand treatmentand care for HIV(STRETCH) ... care clinics and hospitals are referred to ART assessment sites for further clinical care and assessment of eligibility for ART. Those eligible for ART receive drug readinesstraining and are then...
... expertise: theory and implications. Academic Medicine1990, 65(10):611-621.26. Charlin B: Scripts and medical diagnostic knowledge: theory and application for clinical reasoning, instruction and research. ... National HeartFoundation of Australia, Cardiac Society of Australia and New Zealand Guidelines for the management of acute coro-nary syndromes 2006. MJA 2006, 184:S9-S29.52. Chew D, Amerena J, Coverdale ... Discordant Practice Rate (Mean, SD) For patients under my care, the percentage with an acute coronary syndrome who have no contraindications and are discharged on [treatment] is approximately 27.40...
... Discordant Practice Rate (Mean, SD) For patients under my care, the percentage with an acute coronary syndrome who have no contraindications and are discharged on [treatment] is approximately 27.40 ... investigated thinking styles and awareness,knowledge, and behaviours of male doctors in relation tonewly published acute coronary syndrome guidelines.Higher preference for an experiential mode ... study,interpreting the data, writing, and publishing the report.Authors' contributionsRMS, PAP and MJB conceived and designed this study,with contributions from LTH and DPBC. RMS and LTHundertook all...
... 1 of 8(page number not for citation purposes)Globalization and HealthOpen AccessReviewMedicines andvaccinesfor the world's poorest: Is there any prospect for public-private cooperation?Richard ... agencies, and manydeveloping countries. While much of the push has been tolower prices on branded drugs and permit use of cheapergenerics, there is also a growing effort to increase R&D in vaccines ... thebest bang for the buck and should not be neglected in anyAIDS control program [17]. Prevention should be a keypriority for governments and donors.Industry Concerns: The Case for Property...
... widely used in China and Japan fortreatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). We searched literature on CAG between 1995 and 2010 and performed a meta-analysis ... the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol ... all AML and MDS patients. For 5 and reviews were excluded. Several reports had duplicate or overlapping information. Only the latest updated reports were included for meta-analysis. For two...
... 0.1% SDS at 55°C for 1 hour, once in 2 XSSC at 55°C for 15 min, once in 2 X SSC with 10 µg/mlRNase A at 37°C for 30 min and then rinsed twice in 2 XSSC at room temperature for 15 min. Membranes ... NCI-H441, and hu-man fetal lung explants. H441 cells resemble bronchiolarepithelial Clara cells in phenotype and produce both SP-A and SP-B mRNA and protein [14]. The hormonal regulationof SP-A and ... plus either vehicle or insulin (2.5 µg/ml) for an additional 1, 4, 8 and 24 hours. The cells were thenrinsed and trypsinized, and nuclei from control and treatedcells were harvested. The transcription...